This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

UCLA Relies On Breakthrough 'Big Data' Technology From IBM To Help Patients With Traumatic Brain Injuries

Stocks in this article: IBM

ARMONK, N.Y. and LOS ANGELES, March 26, 2013 /PRNewswire/ -- IBM (NYSE: IBM), and Excel Medical Electronics (EME) are collaborating with the UCLA Department of Neurosurgery in a study to test the effectiveness of a real-time alarm intended to predict rising brain pressure in patients with traumatic brain injuries. The experimental system uses big data analytics software developed by IBM Research and EME that analyzes in real-time streams of vital signs continuously collected from the bedside monitor to spot subtle changes in the patient's pulse, blood and intracranial pressure, heart activity, and respiration, signaling that dangerous high-risk increases in brain pressure are on the way.

(Photo:  http://photos.prnewswire.com/prnh/20130326/NY83606-a )

(Photo:  http://photos.prnewswire.com/prnh/20130326/NY83606-INFO-b )

(Logo: http://photos.prnewswire.com/prnh/20090416/IBMLOGO )

Today, patients with traumatic brain injuries are under constant surveillance by bedside monitors measuring the patient's vital signs, but nurses are only alerted by the bedside monitor alarm when brain pressure crosses a critical threshold. At that point, an instant decision must be made by the nurse or physician to determine if the alarm is false, if the condition is life-threatening, or if immediate action is needed to prevent brain damage or death.

UCLA's study aims to address these questions. UCLA neurointensives will use real-time analysis from thousands of vitals collected and flowing from patients' bedside monitor inside the intensive care unit at Ronald Reagan UCLA Medical Center. The technology's goal is to provide advance warning to physicians and nurses of pending changes in the patient's condition, allowing them to take preventive action to keep patients safe from rising brain pressure. For more information on the study click here to view the video: http://youtu.be/bmT6i-fQLck.

The Centers for Disease Control estimates 1.7 million people in the United States sustain a traumatic brain injury every year. Of those individuals, about 52,000 die, 275,000 are hospitalized, and 1.365 million are treated and released from an emergency department. Research has been underway for several years to monitor and predict critical changes in these patients, but until now it has been difficult to analyze all of the patient data that flows in real-time. UCLA study's will be testing whether recent advances in streaming analytics software can now make this possible in the critical care setting.

UCLA's Department of Neurosurgery was awarded a $1.2 million grant from the National Institute of Neurological Disorders and Stroke to study intracranial pressure and develop a predictive alarm system. The department has been studying the effect of rising intracranial pressure on brain trauma patients for the past eight years. This research is now being expanded with the collaboration of IBM and Excel Medical Electronics.

IBM InfoSphere Streams software, part of IBM's big data platform, can analyze and share data in motion, providing real-time decision making in environments where thousands of decisions can be made every second. EME BedMasterEx analytics software collects, stores, reviews, and distributes patient data from hospital monitors and medical devices. EME collaborated with researchers from IBM's T.J. Watson Laboratory to integrate its application with IBM software and develop an easy-to-use interface for medical staff.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,239.60 +48.23 0.28%
S&P 500 2,001.36 -0.80 -0.04%
NASDAQ 4,625.8940 -12.10 -0.26%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs